GHK-Cu Research Guide: Copper Peptide in Skin & Tissue Studies

GHK is a tripeptide with the sequence glycine-histidine-lysine that occurs naturally in human plasma. It has a high affinity for copper(II), and the resulting GHK-Cu complex is the bioactive form most commonly studied in research literature.

Endogenous GHK-Cu levels are estimated at ~200 ng/mL at age 20, falling to ~80 ng/mL by age 60 — one reason GHK-Cu has been investigated as a regenerative research compound.

Microarray work by Pickart and colleagues reported GHK-Cu significantly modifies the expression of approximately 4,000 human genes in cell culture systems — roughly one-third of the human genome — making it one of the broadest signaling peptides described in the literature.

Consistently upregulated pathways include DNA repair, antioxidant defense, collagen and elastin synthesis, and extracellular matrix remodeling. Downregulated pathways include inflammatory cytokine production and fibrotic signaling.

GHK-Cu has been studied in dermal fibroblast cultures, wound-healing models, and hair-follicle research, with reported effects on collagen synthesis, glycosaminoglycan production, and capillary formation.

Topical formulations have appeared in published clinical cosmetic research, but injectable use in research animals remains the primary context for the mechanistic literature.

Research-grade GHK-Cu should be ≥99% pure by HPLC with copper content verified. Redline Bio GHK-Cu ships with batch documentation; independent COAs are published on the lab reports page as third-party testing completes.

GHK-Cu is sold for laboratory research use only. Not for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable regulations.